L. Roy Papp & Associates LLP Has $2.04 Million Position in Colgate-Palmolive (NYSE:CL)

L. Roy Papp & Associates LLP cut its position in Colgate-Palmolive (NYSE:CL) by 1.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,998 shares of the company’s stock after selling 400 shares during the period. L. Roy Papp & Associates LLP’s holdings in Colgate-Palmolive were worth $2,038,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock worth $6,368,378,000 after purchasing an additional 416,853 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Colgate-Palmolive by 27.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after buying an additional 8,933,912 shares during the period. Norges Bank acquired a new stake in Colgate-Palmolive in the 4th quarter valued at approximately $731,843,000. GUARDCAP ASSET MANAGEMENT Ltd lifted its stake in Colgate-Palmolive by 4.1% in the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after acquiring an additional 278,150 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in Colgate-Palmolive by 1.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,426,430 shares of the company’s stock worth $352,824,000 after acquiring an additional 77,679 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 0.3 %

Shares of CL traded up $0.26 during mid-day trading on Friday, reaching $104.21. 3,211,125 shares of the company were exchanged, compared to its average volume of 4,362,109. The business has a 50 day simple moving average of $99.02 and a two-hundred day simple moving average of $92.70. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.28 and a current ratio of 1.06. The stock has a market capitalization of $85.50 billion, a PE ratio of 32.90, a PEG ratio of 3.54 and a beta of 0.39. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $104.34.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. The company had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.77 earnings per share. On average, analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date of this dividend was Friday, July 19th. Colgate-Palmolive’s payout ratio is 63.29%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the sale, the insider now owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The disclosure for this sale can be found here. Insiders have sold 41,177 shares of company stock valued at $4,245,835 in the last 90 days. 0.34% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Argus increased their price objective on Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a report on Wednesday, May 15th. Morgan Stanley lifted their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Barclays increased their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Finally, HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.